Long-term outcomes after treatment of femoro-popliteal disease with Zilver PTX: a multicenter real-world study
In real-world practice, Zilver PTX DES in femoro-popliteal segment reveals favorable 5-year results. Despite the high rate of CLTI patients, ffTLR and PP are comparable with already published randomized trial. However, AFS rate remains low.
Authors
- Enrico Epifani
- Antonio Freyrie (ORCID: https://orcid.org/0000-0002-7080-3138)
- Ginevra Pizzarelli (ORCID: https://orcid.org/0000-0001-7280-3142)
- Nicola Tusini
- Aaron Fargion (ORCID: https://orcid.org/0000-0002-2269-6833)
- Gladiol Zenunaj (ORCID: https://orcid.org/0000-0003-0505-7762)
- Claudio Bianchini Massoni (ORCID: https://orcid.org/0000-0003-1953-8073)
- Nicola Cicala (ORCID: https://orcid.org/0009-0003-3683-6360)
- Andrea Andreone
Institutions
- Azienda Unità Sanitaria Locale di Ferrara (IT)
- Arcispedale Sant'Anna (IT)
Publication Details
- Journal
- International Angiology
- Published
- 2025-09-23
- DOI
- https://doi.org/10.23736/s0392-9590.25.05432-x
- Primary Topic
- Orthopaedic implants and arthroplasty
- Type
- article
- Field-Weighted Citation Impact
- 0.00